Expression of concern

Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia

Paper Information

Record ID:

23231

Author(s):

Marty Hinz
Alvin Stein
Ted Cole

Journal:

Clinical Pharmacology: Advances and Applications ( Taylor and Francis - Dove Press )

Publication Date:

November 14, 2014

Retraction Date:

April 23, 2020 (5.6 years years ago)

Subject:

Broad Categories:
Medicine

Specific Fields:
Medicine - Neurology

Institutions:

Country:

🇺🇸 United States

Article Type:

Research Article

Publisher:

Taylor and Francis - Dove Press

Open Access:

Yes

DOI:

10.2147/CPAA.S72234

PubMed ID:

25484598

Retraction PubMed ID:

32425619

Expression of concern Details

Retraction Reasons:

Nature of Retraction:

Expression of concern

Retraction Notice:

10.2147/CPAA.S240233

Citations (13)

13

Total Citations

3

Post-Retraction
(23.1%)

10

Pre-Retraction

0

Same Day

Post-Retraction Citation Analysis

0 Within 30 days

2 Within 1 year

0 After 2+ years

693 Days since retraction (latest)

Sıçanlarda 6-hidroksidopamin modeli ile oluşturulan Parkinson hastalığında valproik asit tedavisinin dopaminerjik nöronal kayıp üzerindeki anti-apoptotik etkileri

Alev Cumbul, Signem EYUBOGLU, Elif Çiğdem Keleş et al. (5 authors)

Anadolu Kliniği Tıp Bilimleri Dergisi Open Access

Published: Mar 2022

693 days after retraction

Accelerated habitual learning resulting from L-dopa exposure in rats is prevented by N-acetylcysteine

Anne S. Gibson, Kristen A. Keefe, Teri M. Furlong

Pharmacology Biochemistry and Behavior Open Access

Published: Sep 2020
8 citations

132 days after retraction

Paper citing Parkinson’s Disease: Carbidopa, Nausea, and Dyskin...

Unknown Authors

Unknown Journal

Published: Sep 2020

131 days after retraction

The art of suicidal molecular seduction for targeting drug resistance

Mohammad Hassan Moshafi, Saeid Ghasemshirazi, Ardavan Abiri

Medical Hypotheses

Published: Mar 2020
1 citation

38 days before retraction

Selective and competitive inhibition of kynurenine aminotransferase 2 by glycyrrhizic acid and its analogues

Yukihiro Yoshida, Hidetsugu Fujigaki, Koichi Kato et al. (11 authors)

Scientific Reports Open Access

Published: Jul 2019
24 citations

283 days before retraction

Pharmacokinetics, metabolism and safety of deuterated L-DOPA (SD-1077)/carbidopa compared to L-DOPA/carbidopa following single oral dose administration in healthy subjects

Frank Schneider, Lavi Erisson, Hooman Beygi et al. (15 authors)

British Journal of Clinical Pharmacology Open Access

Published: Jun 2018
35 citations

663 days before retraction

Improvement of kynurenine aminotransferase-II inhibitors guided by mimicking sulfate esters

Gayan Jayawickrama, Alireza Nematollahi, Guanchen Sun et al. (4 authors)

PLoS ONE Open Access

Published: Apr 2018
13 citations

730 days before retraction

Linagliptin potentiates the effect of l-dopa on the behavioural, biochemical and immunohistochemical changes in experimentally-induced Parkinsonism: Role of toll-like receptor 4, TGF-β1, NF-κB and glucagon-like peptide 1

Ahmed M. Kabel, Mohamed S. Omar, A. Alhadhrami et al. (5 authors)

Physiology & Behavior

Published: Feb 2018
40 citations

805 days before retraction

Inhibition of human kynurenine aminotransferase isozymes by estrogen and its derivatives

Gayan Jayawickrama, Alireza Nematollahi, Guanchen Sun et al. (5 authors)

Scientific Reports Open Access

Published: Dec 2017
49 citations

867 days before retraction

Management of Parkinson's disease in Ayurveda: Medicinal plants and adjuvant measures

Namyata Pathak- Gandhi, Ashok Vaidya

Journal of Ethnopharmacology

Published: Aug 2016
55 citations

1342 days before retraction

Expanding the repertoire of L-DOPA’s actions: A comprehensive review of its functional neurochemistry

Philippe De Deurwaerdère, Giuseppe Di Giovanni, Mark J. Millan

Progress in Neurobiology

Published: Jul 2016
114 citations

1389 days before retraction

Study of the Activity and Possible Mechanism of Action of a Reversible Inhibitor of Recombinant Human KAT-2: A Promising Lead in Neurodegenerative and Cognitive Disorders

Alireza Nematollahi, Guanchen Sun, Gayan Jayawickrama et al. (5 authors)

Molecules Open Access

Published: Jun 2016
19 citations

1394 days before retraction

Parkinson&rsquo;s disease managing reversible neurodegeneration

Marty Hinz, Alvin Stein, Ted Cole et al. (5 authors)

Neuropsychiatric Disease and Treatment Open Access

Published: Apr 2016
3 citations

1483 days before retraction

Related Records

This article has multiple records in the database due to different notices:

Record #26496

Mar 03, 2021

Retraction

Quick Stats

Total Citations: 13

Years Since Retraction: 5.6 years

Open Access: Yes

Last Checked: Jul 24, 2025

Actions

More from this journal Similar subjects View Original Paper View Retraction Notice